ZELICAPAVIR

UNII:	U4OI721DMD
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₇H₂₂F₃N₇O₃
Preferred Substance Name:	ZELICAPAVIR
InChIKey:	VGGNPZNYTJXPEW-HSZRJFAPSA-N
GSRS Full Record:	U4OI721DMD i

2070852-76-3
(3S)-3-({5-[3-(morpholin-4-yl)-5-(trifluoromethyl)pyridin-2-yl]-1,3,4-oxadiazol-2-yl}amino)-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one
(3S)-3-[[5-[3-morpholin-4-yl-5-(trifluoromethyl)-2-pyridinyl]-1,3,4-oxadiazol-2-yl]amino]-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one
(S)-3-((5-(3-morpholino-5-(trifluoromethyl)pyridin-2-yl)-1,3,4-oxadiazol-2-yl)amino)-5-phenyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one
2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-3-[[5-[3-(4-morpholinyl)-5-(trifluoromethyl)-2-pyridinyl]-1,3,4-oxadiazol-2-yl]amino]-5-phenyl-, (3S)-
EDP-938
ZELICAPAVIR [USAN]
Zelicapavir
Zelicapavir [WHO-DD]
zelicapavir [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ZELICAPAVIR

Synonyms and Mappings

Resources